SOM Biotech has completed in-vitro analyses and identified three drug candidates that can be potentially used to treat Covid-19.
The three candidates inhibit the main protease of SARS-CoV-2, which causes Covid-19, in turn targeting the virus’ replication.
SOM Biotech partnered with Ewha Woman’s University in South Korea for Covid-19 research. The company’s artificial intelligence (AI)-based screening technology, SOMAIPRO, was used to discover the inhibitors of 3CL proteases of SARS-CoV-2, SARS-CoV and MERS-CoV.
These inhibitors were intended to offer potential Covid-19 treatments. Ewha Woman’s University professor Dong-Hae Shin said: “We are very proud about working on promising Covid-19 treatments and contributing to finding effective,